BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19523842)

  • 1. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.
    Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.
    Szabó G; Seres L; Soós P; Gorenflo M; Merkely B; Horkay F; Karck M; Radovits T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):695-700. PubMed ID: 21324707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass.
    Veres G; Radovits T; Otila G; Hirschberg K; Haider H; Krieger N; Knoll A; Weigang E; Szabolcs Z; Karck M; Szabó G
    Thorac Cardiovasc Surg; 2010 Mar; 58(2):86-92. PubMed ID: 20333570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
    Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
    Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation.
    Loganathan S; Radovits T; Hirschberg K; Korkmaz S; Barnucz E; Karck M; Szabó G
    Transplantation; 2008 Nov; 86(10):1414-8. PubMed ID: 19034012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
    Korkmaz S; Radovits T; Barnucz E; Neugebauer P; Arif R; Hirschberg K; Loganathan S; Seidel B; Karck M; Szabó G
    Eur J Pharmacol; 2009 Aug; 615(1-3):155-62. PubMed ID: 19482016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.
    Veres G; Radovits T; Merkely B; Karck M; Szabó G
    J Cardiothorac Surg; 2015 Feb; 10():27. PubMed ID: 25890005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
    Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
    J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
    Hirschberg K; Radovits T; Loganathan S; Entz L; Beller CJ; Gross ML; Sandner P; Karck M; Szabó G
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1508-14. PubMed ID: 19464472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R; Hwang YC; Liu Y; Son NH; Ma N; Parkinson J; Sciacca R; Albala A; Edwards N; Szabolcs MJ; Cannon PJ
    Circulation; 2004 Apr; 109(13):1668-73. PubMed ID: 15051645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus.
    Radovits T; Bömicke T; Kökény G; Arif R; Loganathan S; Kécsán K; Korkmaz S; Barnucz E; Sandner P; Karck M; Szabó G
    Br J Pharmacol; 2009 Mar; 156(6):909-19. PubMed ID: 19298393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
    Royl G; Balkaya M; Lehmann S; Lehnardt S; Stohlmann K; Lindauer U; Endres M; Dirnagl U; Meisel A
    Brain Res; 2009 Apr; 1265():148-57. PubMed ID: 19368809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass.
    Radovits T; Beller CJ; Groves JT; Merkely B; Karck M; Szabó C; Szabó G
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):391-6. PubMed ID: 21733708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.
    Allen BS; Veluz JS; Buckberg GD; Aeberhard E; Ignarro LJ
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):625-32. PubMed ID: 12658205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial cyclic AMP augmentation with high-dose PDEIII inhibitor in terminal warm blood cardioplegia.
    Ko Y; Morita K; Nagahori R; Kinouchi K; Shinohara G; Kagawa H; Hashimoto K
    Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):311-7. PubMed ID: 19901885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inosine on reperfusion injury after heart transplantation.
    Szabó G; Stumpf N; Radovits T; Sonnenberg K; Gerö D; Hagl S; Szabó C; Bährle S
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):96-102. PubMed ID: 16730445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.